- United States
- /
- Aerospace & Defense
- /
- NYSE:BETA
Assessing BETA Technologies (BETA) After Sharp Share Price Slide And Valuation Check
- If you are wondering whether BETA Technologies at around US$16.65 is a bargain or a value trap, you are not alone. This article is here to unpack what the current price might be implying.
- The stock has had a rough patch recently, with a 13.6% decline over the last 7 days, a 14.1% decline over the last 30 days, and a 39.1% decline year to date, which can change how the market views both its potential and its risk.
- Recent news coverage has focused on BETA Technologies as part of broader discussions about capital goods names on the NYSE, including how investors are reassessing growth stories in that space. This context has kept attention on whether recent share price moves are driven more by sentiment or by fundamentals tied to BETA Technologies specifically.
- Against that backdrop, BETA Technologies currently scores a 5 out of 6 on our valuation checks, which suggests the market price may not fully reflect the outcomes of several standard valuation tests. Next, we will walk through those methods and then finish with a broader way of thinking about what valuation really means for long term investors.
Approach 1: BETA Technologies Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back into today’s dollars, aiming to estimate what the whole business might be worth right now.
For BETA Technologies, the model used is a 2 Stage Free Cash Flow to Equity approach that relies on cash flow projections in $. The latest twelve month free cash flow is a loss of $414.5 million. Analyst inputs and extrapolated estimates point to free cash flow of $494.5 million in 2030, with a path that includes projected losses through 2028 before moving into positive territory in 2029 and beyond.
When all projected cash flows from 2026 through 2035 are discounted back and combined with a longer term assumption, the model arrives at an estimated intrinsic value of about $146.73 per share. Compared to the recent share price of around $16.65, this implies the stock is about 88.7% undervalued based on this specific set of assumptions and inputs.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests BETA Technologies is undervalued by 88.7%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.
Approach 2: BETA Technologies Price vs Book
For companies where earnings are not yet a steady guide, the price to book, or P/B, ratio can be a useful way to think about value, because it relates the share price to the accounting value of net assets on the balance sheet.
Investors usually expect higher P/B multiples when they see stronger growth potential or lower perceived risk, and lower P/B multiples when growth is uncertain or risks feel higher. That is why what counts as a “normal” or “fair” P/B ratio can vary widely from one company or industry to another.
BETA Technologies currently trades on a P/B ratio of 2.10x. This sits below the Aerospace & Defense industry average of 4.16x and also below the peer group average of 2.93x. Simply Wall St’s “Fair Ratio” is a proprietary estimate of what a justified P/B might be for BETA Technologies, based on factors such as growth profile, risks, profit margins, industry and market capitalization. Compared with simple peer or industry comparisons, the Fair Ratio aims to give a more tailored reference point that reflects the specifics of this business. As the Fair Ratio for BETA Technologies is not available here, it is not possible to use it to judge whether the current 2.10x multiple suggests the stock is overvalued or undervalued.
Result: ABOUT RIGHT
P/B ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.
Upgrade Your Decision Making: Choose your BETA Technologies Narrative
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce Narratives, which let you describe your view of BETA Technologies as a story behind the numbers by tying your assumptions about future revenue, earnings and margins into a financial forecast, linking that forecast to a Fair Value, and then comparing that Fair Value with the current share price. This can help you decide whether to buy, hold or sell, all within an easy tool on Simply Wall St's Community page that updates as new news or earnings arrive. It can also show very different perspectives, such as one investor building a cautious Narrative around a Fair Value of US$30.00, while another builds a more upbeat Narrative around a Fair Value of US$45.00.
Do you think there's more to the story for BETA Technologies? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if BETA Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:BETA
BETA Technologies
An electric aerospace company, designs, manufactures, and sells electric aircraft, electric propulsion systems, components, and charging systems worldwide.
Undervalued with adequate balance sheet.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives
Wise: A Quality Cross-Border Payments Compounder, But Not A Bargain
Diversified Energy's Profit Margin Set to Skyrocket 27%
BBWI VALUATION
Popular Narratives
QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026
